DE602004016532D1 - Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren - Google Patents

Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren

Info

Publication number
DE602004016532D1
DE602004016532D1 DE602004016532T DE602004016532T DE602004016532D1 DE 602004016532 D1 DE602004016532 D1 DE 602004016532D1 DE 602004016532 T DE602004016532 T DE 602004016532T DE 602004016532 T DE602004016532 T DE 602004016532T DE 602004016532 D1 DE602004016532 D1 DE 602004016532D1
Authority
DE
Germany
Prior art keywords
imaging
detectable species
imaging agents
kits
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004016532T
Other languages
English (en)
Inventor
Bruce Fletcher Johnson
Tiberiu Mircea Siclovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Co
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Electric Co filed Critical General Electric Co
Publication of DE602004016532D1 publication Critical patent/DE602004016532D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE602004016532T 2003-08-26 2004-07-06 Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren Expired - Lifetime DE602004016532D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/647,979 US20050049487A1 (en) 2003-08-26 2003-08-26 Compounds and kits for preparing imaging agents and methods of imaging
PCT/US2004/021600 WO2005023317A1 (en) 2003-08-26 2004-07-06 Compounds and kits for preparing imaging agents and methods of imaging

Publications (1)

Publication Number Publication Date
DE602004016532D1 true DE602004016532D1 (de) 2008-10-23

Family

ID=34216641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004016532T Expired - Lifetime DE602004016532D1 (de) 2003-08-26 2004-07-06 Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren

Country Status (7)

Country Link
US (1) US20050049487A1 (de)
EP (1) EP1658099B1 (de)
JP (1) JP5030589B2 (de)
AT (1) ATE407703T1 (de)
DE (1) DE602004016532D1 (de)
ES (1) ES2313075T3 (de)
WO (1) WO2005023317A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565860B2 (en) 2000-08-21 2013-10-22 Biosensors International Group, Ltd. Radioactive emission detector equipped with a position tracking system
US20040204646A1 (en) * 2002-11-04 2004-10-14 V-Target Technologies Ltd. Intracorporeal-imaging head
US8586932B2 (en) 2004-11-09 2013-11-19 Spectrum Dynamics Llc System and method for radioactive emission measurement
WO2006051531A2 (en) * 2004-11-09 2006-05-18 Spectrum Dynamics Llc Radioimaging
US7176466B2 (en) 2004-01-13 2007-02-13 Spectrum Dynamics Llc Multi-dimensional image reconstruction
US7968851B2 (en) 2004-01-13 2011-06-28 Spectrum Dynamics Llc Dynamic spect camera
WO2007010534A2 (en) 2005-07-19 2007-01-25 Spectrum Dynamics Llc Imaging protocols
US8571881B2 (en) * 2004-11-09 2013-10-29 Spectrum Dynamics, Llc Radiopharmaceutical dispensing, administration, and imaging
US9040016B2 (en) 2004-01-13 2015-05-26 Biosensors International Group, Ltd. Diagnostic kit and methods for radioimaging myocardial perfusion
EP1778957A4 (de) 2004-06-01 2015-12-23 Biosensors Int Group Ltd Optimierung der messung radioaktiver strahlung an besonderen körperstrukturen
US8423125B2 (en) * 2004-11-09 2013-04-16 Spectrum Dynamics Llc Radioimaging
US9316743B2 (en) 2004-11-09 2016-04-19 Biosensors International Group, Ltd. System and method for radioactive emission measurement
US9943274B2 (en) 2004-11-09 2018-04-17 Spectrum Dynamics Medical Limited Radioimaging using low dose isotope
US8615405B2 (en) * 2004-11-09 2013-12-24 Biosensors International Group, Ltd. Imaging system customization using data from radiopharmaceutical-associated data carrier
WO2008059489A2 (en) 2006-11-13 2008-05-22 Spectrum Dynamics Llc Radioimaging applications of and novel formulations of teboroxime
EP1731911A1 (de) * 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verfahren zum Nachweis von Enzephalopathien
US8837793B2 (en) 2005-07-19 2014-09-16 Biosensors International Group, Ltd. Reconstruction stabilizer and active vision
US8894974B2 (en) * 2006-05-11 2014-11-25 Spectrum Dynamics Llc Radiopharmaceuticals for diagnosis and therapy
US9275451B2 (en) * 2006-12-20 2016-03-01 Biosensors International Group, Ltd. Method, a system, and an apparatus for using and processing multidimensional data
EP2112911B1 (de) * 2007-02-22 2014-10-01 Ramot at Tel-Aviv University Ltd. Vorrichtung zur behandlung von blutgefässen mit ultraschall
US8338788B2 (en) 2009-07-29 2012-12-25 Spectrum Dynamics Llc Method and system of optimized volumetric imaging
US20220072163A1 (en) * 2018-07-03 2022-03-10 The Regents Of The University Of California Mild and site-selective 18f-labeling of small molecules and/or biomolecules via a thiol-reactive synthon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659517A (en) * 1984-10-22 1987-04-21 Bio-Medical Research Laboratories, Inc. Halogen labeled compounds including estradiol derivatives, their synthetic intermediates and the syntheses thereof
US4775759A (en) * 1984-11-27 1988-10-04 The United States Of America As Represented By The Department Of Health And Human Services Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US5264570A (en) * 1992-08-05 1993-11-23 General Electric Company Method for making 2-[18 F]fluoro-2-deoxy-D-glucose
GB9309795D0 (en) * 1993-05-12 1993-06-23 Rhone Poulenc Chemicals Preparation of flouro-compounds
BE1010280A3 (fr) * 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
EP1044697A1 (de) * 1999-04-15 2000-10-18 Mac Clay, Fernando, Horacio Einwegspritze
US6696039B2 (en) * 2001-04-23 2004-02-24 Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
GB0115927D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
CA2456411C (en) * 2001-08-27 2011-02-15 The Trustees Of The University Of Pennsylvania Stilbene derivatives and their use for binding and imaging amyloid plaques
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles

Also Published As

Publication number Publication date
WO2005023317A1 (en) 2005-03-17
EP1658099A1 (de) 2006-05-24
US20050049487A1 (en) 2005-03-03
JP5030589B2 (ja) 2012-09-19
ES2313075T3 (es) 2009-03-01
ATE407703T1 (de) 2008-09-15
JP2007503438A (ja) 2007-02-22
EP1658099B1 (de) 2008-09-10

Similar Documents

Publication Publication Date Title
DE602004016532D1 (de) Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren
US20220025444A1 (en) On-slide staining by primer extension
Ahmad Fuaad et al. Peptide conjugation via CuAAC ‘click’chemistry
Lee et al. Discovery of E3 ligase ligands for target protein degradation
BRPI0516463A (pt) cánula escalonada e conjunto de cánula
DK1874818T3 (da) TGF-Beta 1-specifikke antistoffer
WO2005062977A3 (en) Prostate cancer specific internalizing human antibodies
Lemos Addition and cycloaddition reactions of phosphinyl-and phosphonyl-2 H-azirines, nitrosoalkenes and azoalkenes
EA200602196A1 (ru) Производные пиразола, композиции, содержащие эти соединения, и способы применения
Fernández et al. Spirolactams as conformationally restricted pseudopeptides: synthesis and conformational analysis
NO20053809L (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
Wahba et al. New one-pot methodologies for the modification or synthesis of alkaloid scaffolds
Ferreira et al. Synthesis, DNA-binding and antiproliferative properties of acridine and 5-methylacridine derivatives
ATE355259T1 (de) Radiofluorierungsverfahren
Paris et al. Exploiting protected maleimides to modify oligonucleotides, peptides and peptide nucleic acids
Schaff et al. Update on novel therapeutics for primary CNS lymphoma
DE602005019722D1 (de) Substituierte pyrrolidin-2-one
Figazzolo et al. Enzymatic synthesis of vancomycin-modified DNA
WO2003105773A3 (en) MUTATIONS OF PDGFRA ACTIVATED AS DIAGNOSTIC MARKERS AND THERAPEUTIC TARGETS
Brzezinska et al. 2-Pyridinyl-N-(2, 4-Difluorobenzyl) aminoethyl group as thermocontrolled implement for protection of carboxylic Acids
O’Malley et al. Cellular uptake and photo-cytotoxicity of a Gadolinium (III)-DOTA-Naphthalimide complex “clicked” to a lipidated tat peptide
Ban et al. Nucleobase–guanidiniocarbonyl-pyrrole conjugates as novel fluorimetric sensors for single stranded RNA
EA200800948A1 (ru) Биотиндиаминопроизводные и их конъюгаты с макроциклическими хелатирующими реагентами
ATE532509T1 (de) Mittel zur hemmung des eintritts des hiv-virus
Chardet et al. Convertible and Constrained Nucleotides: The 2’-Deoxyribose 5’-C-Functionalization Approach, a French Touch

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS LLP, LONDON, GB

R082 Change of representative

Ref document number: 1658099

Country of ref document: EP

Representative=s name: J D REYNOLDS & CO., GB